Centenial Surgical Suture Ltd.
BSE: CSURGSU · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Centenial Surgical Suture Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Centenial Surgical Suture Limited is an Indian medical device manufacturer specialising in the production and distribution of surgical sutures and medical needles. The company provides a diverse range of absorbable and non-absorbable materials to support various surgical specialties, including cardiovascular and oncology procedures.
Business Model
The company generates revenue through the manufacturing and sale of specialized medical consumables to government hospitals, private healthcare institutions, and international export clients. Its business model relies on maintaining high quality standards and regulatory compliance to serve both domestic and global medical markets.
Management Commentary
Management focuses on maintaining a strong presence in the specialized medical consumables segment through rigorous quality control and regulatory adherence. There is a strategic emphasis on serving a broad spectrum of healthcare providers ranging from public hospitals to private surgical centres.
Growth Outlook
Growth is driven by the increasing demand for high-quality surgical consumables across domestic and international healthcare markets. The company aims to leverage its manufacturing capabilities to expand its footprint in specialized surgical segments.
Key Risks
- Regulatory Compliance Risk. Failure to maintain stringent international and domestic quality standards could lead to product recalls or loss of manufacturing licences.
- Market Competition. The medical device sector is highly competitive, with pressure from both large multinational corporations and low-cost domestic manufacturers.
- Supply Chain Volatility. Fluctuations in the cost and availability of raw materials like polyglycolic acid, silk, and nylon may impact profit margins.
- Export Dependency. Exposure to international markets introduces risks related to currency fluctuations and varying healthcare regulations across different jurisdictions.
Start your research today
Unlock AI insights, financials, peers and live data on Centenial Surgical Suture Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹54 Cr
TTM · standalone
NET PROFIT
₹3 Cr
TTM · standalone
EPS
₹6.88
TTM · standalone
RETURN ON EQUITY
8.3%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
11.3%
TTM · standalone
P/E
13.0x
Q4 FY26 · standalone
EV/EBITDA
4.4x
Q4 FY26 · standalone
EBITDA MARGIN
18.2%
TTM · standalone
NET PROFIT MARGIN
18.4%
Q4 FY26 · standalone
DEBT TO EQUITY
0.4x
Q4 FY26 · standalone
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Centenial Surgical Suture Ltd.CSURGSU | ₹34 Cr | 13.72 | 4.58 | 0.6% | 18.2% | 8.3% | 11.3% | -21.3% |
Tarsons ProductsTARSONS | ₹1,768 Cr | 158.97 | 14.57 | 10.6% | 33.1% | 1.8% | 4.5% | +6.6% |
Laxmi DentalLAXMIDENTL | ₹1,098 Cr | 35.30 | 19.82 | — | 19.2% | 13.7% | 13.3% | -41.5% |
Vasa Denticity LimitedDENTALKART | ₹709 Cr | — | — | — | 4.0% | — | — | -34.1% |
Hemant Surgical Industries LimitedHSIL | ₹539 Cr | — | — | — | 10.0% | — | — | +27.0% |
Prevest DenproPREVEST | ₹464 Cr | — | — | — | 36.0% | — | — | -31.5% |
As of Q4 FY26
Financials
Centenial Surgical Suture Ltd.
BSE: CSURGSU · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Centenial Surgical Suture Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Centenial Surgical Suture Limited is an Indian medical device manufacturer specialising in the production and distribution of surgical sutures and medical needles. The company provides a diverse range of absorbable and non-absorbable materials to support various surgical specialties, including cardiovascular and oncology procedures.
Business Model
The company generates revenue through the manufacturing and sale of specialized medical consumables to government hospitals, private healthcare institutions, and international export clients. Its business model relies on maintaining high quality standards and regulatory compliance to serve both domestic and global medical markets.
Management Commentary
Management focuses on maintaining a strong presence in the specialized medical consumables segment through rigorous quality control and regulatory adherence. There is a strategic emphasis on serving a broad spectrum of healthcare providers ranging from public hospitals to private surgical centres.
Growth Outlook
Growth is driven by the increasing demand for high-quality surgical consumables across domestic and international healthcare markets. The company aims to leverage its manufacturing capabilities to expand its footprint in specialized surgical segments.
Key Risks
- Regulatory Compliance Risk. Failure to maintain stringent international and domestic quality standards could lead to product recalls or loss of manufacturing licences.
- Market Competition. The medical device sector is highly competitive, with pressure from both large multinational corporations and low-cost domestic manufacturers.
- Supply Chain Volatility. Fluctuations in the cost and availability of raw materials like polyglycolic acid, silk, and nylon may impact profit margins.
- Export Dependency. Exposure to international markets introduces risks related to currency fluctuations and varying healthcare regulations across different jurisdictions.
Start your research today
Unlock AI insights, financials, peers and live data on Centenial Surgical Suture Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹54 Cr
TTM · standalone
NET PROFIT
₹3 Cr
TTM · standalone
EPS
₹6.88
TTM · standalone
RETURN ON EQUITY
8.3%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
11.3%
TTM · standalone
P/E
13.0x
Q4 FY26 · standalone
EV/EBITDA
4.4x
Q4 FY26 · standalone
EBITDA MARGIN
18.2%
TTM · standalone
NET PROFIT MARGIN
18.4%
Q4 FY26 · standalone
DEBT TO EQUITY
0.4x
Q4 FY26 · standalone
Peers · Medical Equipment & Supplies
As of Q4 FY26